• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

初发未用药的精神分裂症患者与健康对照者在独自步行月数和脑源性神经营养因子(BDNF)水平上存在差异。

The month of walking alone and BDNF level differ between drug-naive first-episode schizophrenia patients and healthy controls.

作者信息

Zhang Zhenmei, Fan Lejia, Yuan Liu, Li Zongchang, Ouyang Lijun, Ma Xiaoqian, Yang Zihao, Lv Jingyan, Chen Shuting, Chen Xiaogang, He Ying

机构信息

National Clinical Research Center for Mental Disorders, Department of Psychiatry, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.

Hunan Key Laboratory of Psychiatry and Mental Health, China National Technology Institute on Mental Disorders, Institute of Mental Health, Hunan Medical Center for Mental Health, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.

出版信息

Front Mol Neurosci. 2023 May 10;16:1177524. doi: 10.3389/fnmol.2023.1177524. eCollection 2023.

DOI:10.3389/fnmol.2023.1177524
PMID:37234686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10206054/
Abstract

INTRODUCTION

Schizophrenia is a neurodevelopmental disorder, characterized by impairment in reasoning, affectivity, and social relationships. Previous studies have shown delayed motor development and Brain-Derived Neurotrophic Factor (BDNF) level change in individuals with schizophrenia. We researched the month of walking alone (MWA) and BDNF level between drug-naive first-episode schizophrenia patients (FEP) and healthy control (HC), as well as how they behave in neurocognitive function and severity of symptoms. Predictors of schizophrenia were further explored too.

METHODS

We researched the MWA and BDNF levels between FEP and HCs in the Second Xiangya Hospital of Central South University from August 2017 to January 2020, as well as how they behave in neurocognitive function and the severity of symptoms. A binary logistic regression analysis was used to examine the risk factors affecting the onset and treatment outcome of schizophrenia.

RESULTS

We find that FEP showed a walking delay and lower BDNF levels compared to HCs, which were associated with cognitive impairment and severity of symptoms. According to the difference and correlation analysis results, and combined with the appropriate application conditions for binary logistic regression, Wechsler Intelligence Scale Picture completion, Hopkins Verbal Learning Test-Revised, and Trail Making Test: part A were added to the binary logistic regression analysis to distinguish FEP and HCs.

CONCLUSION

Our study has shown delayed motor development and changes in BDNF levels in schizophrenia, extending insight into the early identification of patients with schizophrenia versus healthy populations.

摘要

引言

精神分裂症是一种神经发育障碍,其特征在于推理、情感和社会关系方面的损害。先前的研究表明,精神分裂症患者存在运动发育延迟和脑源性神经营养因子(BDNF)水平变化。我们研究了初发未用药的精神分裂症患者(FEP)和健康对照(HC)之间的独自行走月龄(MWA)和BDNF水平,以及它们在神经认知功能和症状严重程度方面的表现。还进一步探讨了精神分裂症的预测因素。

方法

我们于2017年8月至2020年1月在中南大学湘雅二医院研究了FEP和HC之间的MWA和BDNF水平,以及它们在神经认知功能和症状严重程度方面的表现。采用二元逻辑回归分析来检验影响精神分裂症发病和治疗结果的危险因素。

结果

我们发现,与HC相比,FEP表现出行走延迟和较低的BDNF水平,这与认知障碍和症状严重程度相关。根据差异和相关性分析结果,并结合二元逻辑回归的适用条件,将韦氏智力量表图片填充、修订版霍普金斯言语学习测验和连线测验A部分纳入二元逻辑回归分析以区分FEP和HC。

结论

我们的研究表明精神分裂症存在运动发育延迟和BDNF水平变化,这为精神分裂症患者与健康人群的早期鉴别提供了更多见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6d/10206054/9e997e8ec1ff/fnmol-16-1177524-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6d/10206054/b381ba08cdee/fnmol-16-1177524-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6d/10206054/9e997e8ec1ff/fnmol-16-1177524-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6d/10206054/b381ba08cdee/fnmol-16-1177524-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef6d/10206054/9e997e8ec1ff/fnmol-16-1177524-g002.jpg

相似文献

1
The month of walking alone and BDNF level differ between drug-naive first-episode schizophrenia patients and healthy controls.初发未用药的精神分裂症患者与健康对照者在独自步行月数和脑源性神经营养因子(BDNF)水平上存在差异。
Front Mol Neurosci. 2023 May 10;16:1177524. doi: 10.3389/fnmol.2023.1177524. eCollection 2023.
2
Can the Imbalance between Neurotrophic and Apoptotic Proteins Be the "Beware the Ides of March" for Unaffected Relatives of Schizophrenia Patients?神经营养和凋亡蛋白失衡是否会成为精神分裂症患者未受影响亲属的“三月警惕日”?
Mol Neurobiol. 2022 Dec;59(12):7413-7422. doi: 10.1007/s12035-022-03054-4. Epub 2022 Oct 3.
3
Cognitive impairment in first-episode drug-naïve patients with schizophrenia: Relationships with serum concentrations of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor.首发未用药精神分裂症患者的认知障碍:与脑源性神经营养因子和胶质细胞源性神经营养因子血清浓度的关系。
Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jun 2;76:163-168. doi: 10.1016/j.pnpbp.2017.03.013. Epub 2017 Mar 22.
4
Brain-derived neurotrophic factor levels and psychopathology scores in drug-naïve first-episode psychosis.初发未用药的首发精神病患者脑源性神经营养因子水平与精神病理学评分
Asia Pac Psychiatry. 2020 Dec;12(4):e12415. doi: 10.1111/appy.12415. Epub 2020 Aug 22.
5
A Longitudinal Study of Serum Brain-Derived Neurotrophic Factor Levels in First-Episode Schizophrenia.首发精神分裂症患者血清脑源性神经营养因子水平的纵向研究。
J Clin Psychopharmacol. 2019 Nov/Dec;39(6):639-643. doi: 10.1097/JCP.0000000000001118.
6
Association of serum BDNF levels with hippocampal volumes in first psychotic episode drug-naive schizophrenic patients.首发未用药精神分裂症患者血清脑源性神经营养因子水平与海马体积的相关性。
Schizophr Res. 2011 Jul;129(2-3):201-4. doi: 10.1016/j.schres.2011.03.011. Epub 2011 Apr 5.
7
Investigation of serum BDNF levels in drug-naive patients with schizophrenia.初发未用药精神分裂症患者血清脑源性神经营养因子水平的研究。
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jul 1;32(5):1308-11. doi: 10.1016/j.pnpbp.2008.04.007. Epub 2008 Apr 16.
8
Brain-derived neurotrophic factor (BDNF) levels in first-episode schizophrenia and healthy controls: A comparative study.首发精神分裂症患者与健康对照者脑源性神经营养因子(BDNF)水平的比较研究
Asian J Psychiatr. 2020 Dec;54:102370. doi: 10.1016/j.ajp.2020.102370. Epub 2020 Aug 29.
9
Cognitive impairment in adolescent and adult-onset psychosis: a comparative study.青少年期和成人期发病精神病中的认知障碍:一项比较研究。
Child Adolesc Psychiatry Ment Health. 2024 Sep 28;18(1):122. doi: 10.1186/s13034-024-00815-y.
10
Peripheral Blood Levels of Brain-Derived Neurotrophic Factor in Patients with First Episode Psychosis: A Systematic Review and Meta-Analysis.首发精神病患者外周血脑源性神经营养因子水平:一项系统评价和荟萃分析
Brain Sci. 2022 Mar 22;12(4):414. doi: 10.3390/brainsci12040414.

引用本文的文献

1
A comprehensive review on schizophrenia: epidemiology, pathogenesis, diagnosis, conventional treatments, and proposed natural compounds used for management.精神分裂症综述:流行病学、发病机制、诊断、传统治疗方法及用于治疗的天然化合物研究进展
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun 13. doi: 10.1007/s00210-025-04351-0.

本文引用的文献

1
Impaired motor development in children with familial high risk of schizophrenia or bipolar disorder and the association with psychotic experiences: a 4-year Danish observational follow-up study.精神分裂症或双相情感障碍家族高风险儿童的运动发育受损及其与精神病性体验的关联:一项为期4年的丹麦观察性随访研究。
Lancet Psychiatry. 2023 Feb;10(2):108-118. doi: 10.1016/S2215-0366(22)00402-3. Epub 2023 Jan 4.
2
Association between the improvement in depressive symptoms and serum BDNF levels in drug-naive first episode patients with schizophrenia: A longitudinal follow-up.首发精神分裂症未用药患者抑郁症状改善与血清脑源性神经营养因子水平的相关性:一项纵向随访研究。
Psychoneuroendocrinology. 2021 Nov;133:105392. doi: 10.1016/j.psyneuen.2021.105392. Epub 2021 Aug 18.
3
Brain-derived neurotrophic factor (BDNF) levels in first-episode schizophrenia and healthy controls: A comparative study.首发精神分裂症患者与健康对照者脑源性神经营养因子(BDNF)水平的比较研究
Asian J Psychiatr. 2020 Dec;54:102370. doi: 10.1016/j.ajp.2020.102370. Epub 2020 Aug 29.
4
Trajectory of change in brain complement factors from neonatal to young adult humans.从新生儿到年轻成年人脑补体因子的变化轨迹。
J Neurochem. 2021 May;157(3):479-493. doi: 10.1111/jnc.15241. Epub 2020 Dec 15.
5
BDNF serum levels and cognitive improvement in drug-naive first episode patients with schizophrenia: A prospective 12-week longitudinal study.BDNF 血清水平与首发未用药精神分裂症患者认知改善的相关性:一项前瞻性 12 周纵向研究。
Psychoneuroendocrinology. 2020 Dec;122:104879. doi: 10.1016/j.psyneuen.2020.104879. Epub 2020 Sep 24.
6
Schizophrenia.精神分裂症
N Engl J Med. 2019 Oct 31;381(18):1753-1761. doi: 10.1056/NEJMra1808803.
7
Cognitive deficit in schizophrenia: an overview.精神分裂症认知缺陷:概述。
Psychiatr Danub. 2019 Jun;31(Suppl 2):139-142.
8
Cognitive deficits in subjects at risk for psychosis, first-episode and chronic schizophrenia patients.有精神病风险的受试者、首发和慢性精神分裂症患者的认知缺陷。
Psychiatry Res. 2019 Apr;274:235-242. doi: 10.1016/j.psychres.2019.01.089. Epub 2019 Feb 1.
9
Lactate Mediates the Effects of Exercise on Learning and Memory through SIRT1-Dependent Activation of Hippocampal Brain-Derived Neurotrophic Factor (BDNF).乳酸通过 SIRT1 依赖性激活海马脑源性神经营养因子 (BDNF) 介导运动对学习和记忆的影响。
J Neurosci. 2019 Mar 27;39(13):2369-2382. doi: 10.1523/JNEUROSCI.1661-18.2019. Epub 2019 Jan 28.
10
Olfactory and cognitive functions in Chinese individuals at clinical high risk for psychosis.嗅觉和认知功能在有精神病临床高危的中国个体中。
Psychiatry Res. 2019 Feb;272:51-53. doi: 10.1016/j.psychres.2018.12.074. Epub 2018 Dec 14.